Biopharmaceutical Aspects on the Intranasal Administration of Peptides
- 1 January 1986
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Intranasal drug delivery by spray and dropsJournal of Pharmacy and Pharmacology, 1985
- Plasma concentrations of 1-deamino-8-d-arginine vasopressin after intragastric administration in the ratActa Endocrinologica, 1985
- SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERSThe Lancet, 1984
- Nasal Absorption of Nafarelin Acetate, the Decapeptide [D-Nal(2)6]LHRH, in Rhesus Monkeys IJournal of Pharmaceutical Sciences, 1984
- INTRANASAL ADMINISTRATION OF HUMAN PANCREATIC TUMOR GH-RELEASING FACTOR-40 STIMULATES GH RELEASE IN NORMAL MENJournal of Clinical Endocrinology & Metabolism, 1983
- Distribution and removal of human serum albumin‐technetium 99m instilled intranasally.British Journal of Clinical Pharmacology, 1976
- Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory StudiesBMJ, 1973
- Intranasal oxytocin in eighteen hundred patientsAmerican Journal of Obstetrics and Gynecology, 1971
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963
- NASAL SPRAY OF SYNTHETIC VASOPRESSIN FOR THE TREATMENT OF DIABETES INSIPIDUSThe Lancet, 1963